" class="no-js "lang="en-US"> COVID-19 Archives - Medtech Alert
Monday, October 02, 2023

Sort by:

Date

Top Post

Senhwa Biosciences Received Taiwan FDA IND Approval for Phase II Study of Silmitasertib in Patients with Moderate to Severe COVID-19

Senhwa Biosciences, a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and […]

Pneumagen Further Strengthens IP Protection for Lead Product Neumifil with Granting of US Composition of Matter Patent

Pneumagen, a clinical-stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis […]

ECCMID 2023: Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir Treatment

Shionogi today announced that two late-breaking poster presentations featuring new results from the Phase 3 […]

PharmaJet Announces Clinical Results from Scancell’s COVID-19 DNA Vaccine Study Exclusively Administered with Needle-free Precision Delivery Systems

PharmaJet, a company engineering precision delivery systems that may overcome the challenges of nucleic acid […]

Axcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID Fatigue

Axcella Therapeutics, a clinical-stage biotechnology company pioneering novel approaches to treating complex diseases using multi-targeted […]

U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 Vaccine

Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, […]

Roche launches COVID-19 PCR Test to Detect the Fast Spreading XBB.1.5 Omicron Sub-variant

Roche and its subsidiary TIB Molbiol have developed a COVID-19 PCR test for researchers that […]

Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by China NMPA

Ascletis Pharma has announced that China National Medical Products Administration (NMPA) has approved the Investigational […]

COVID-19 Patients Show Liver Injury Months After Infection

COVID-19 infection is associated with increased liver stiffness, a sign of possible long-term liver injury, […]

Novavax Makes One Million Doses of Nuvaxovid™ Available for Use in the United Kingdom

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more